Registrati | Log in | FAQ      [?] 

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Articles from the last few issues of Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics © Cognizant Communication Corporation
  • Aberrant Promoter CpG Islands Methylation of Tumor Suppressor Genes in Cholangiocarcinoma
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 4. (2008), pp. 151-157.
    by Uhm, Kyung-Ok, Lee, Eun Soo, Lee, Yun Mi, Kim, Hyeon Soo, Park, Young-Nyun, Park, Sun-Hwa
  • Association of Interleukin-18 Gene Promoter Polymorphism on the Risk of Cervix Carcinogenesis in North Indian Population
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 4. (2008), pp. 159-166.
  • Interaction of EGFR 497ArgLys With EGF +61AG Polymorphism: Modulation of Risk in Esophageal Cancer
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 4. (2008), pp. 167-174.
  • Retinoic Acid and Sodium Butyrate as Cell Cycle Regulators in the Treatment of Oral Squamous Carcinoma Cells
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 4. (2008), pp. 175-182.
  • Expression of Heparanase in Hepatocellular Carcinoma Has Prognostic Significance: A Tissue Microarray Study
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 4. (2008), pp. 183-189.
  • Investigation of Pericytes, Hypoxia, and Vascularity in Bladder Tumors: Association With Clinical Outcomes
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 3. (2008), pp. 93-101.
  • Antiproliferative and Apoptotic Effects of Two New Pd(II) Methylsarcosinedithiocarbamate Derivatives on Human Acute Myeloid Leukemia Cells In Vitro
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 3. (2008), pp. 103-113.
  • Aurora-A Transcriptional Silencing and Vincristine Treatment Show a Synergistic Effect in Human Tumor Cells
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 3. (2008), pp. 115-125.
  • Association of Polymorphisms in Base Excision Repair Genes With the Risk of Breast Cancer: A Case-Control Study in North Indian Women
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 3. (2008), pp. 127-135.
  • Long-Term Results of Dose-Intensive Chemotherapy With G-CSF Support (TCC-NHL-91) for Advanced Intermediate-Grade Non-Hodgkin's Lymphoma: A Review of 59 Consecutive Cases Treated at a Single Institute
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 3. (2008), pp. 137-149.
  • Natriuretic Peptides: Biochemical Markers of Anthracycline Cardiac Toxicity?
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 2. (2008), pp. 51-58.
  • aPKC Inhibitors Might be the Sensitizer of Chemotherapy and Adoptive Immunotherapy in the Treatment of hASIPa-Overexpressed Breast Cancer
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 2. (2008), pp. 59-68.
  • RNASET2 as a Tumor Antagonizing Gene in a Melanoma Cancer Model
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 2. (2008), pp. 69-74.
  • Pretreatment With Black Tea Polyphenols Modulates Xenobiotic-Metabolizing Enzymes in an Experimental Oral Carcinogenesis Model
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 2. (2008), pp. 75-85.
    by Vidjaya Letchoumy, , Chandra Mohan, , Stegeman, , Gelboin, , Hara, , Nagini,
  • CCR5-32 Polymorphism and Susceptibility to Cervical Cancer: Association With Early Stage of Cervical Cancer
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 2. (2008), pp. 87-91.
  • Hyperinduction of Wnt Activity: A New Paradigm for the Treatment of Colorectal Cancer?
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 1. (2008), pp. 1-9.
  • Epoxyquinol B Shows Antiangiogenic and Antitumor Effects by Inhibiting VEGFR2, EGFR, FGFR, and PDGFR
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 1. (2008), pp. 11-21.
  • Hepatocyte Growth Factor Promotes Cell Survival by Phosphorylation of BAD in Gastric Cancer Cells
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 1. (2008), pp. 23-32.
    by Lee, Kyung Hee, Choi, Eun Young, Kim, Min Kyoung, Hyun, Myung Soo, Eun, Jong Ryul, Jang, Byung Ik, Kim, Tae Nyeun, Kim, Sang Woon, Song, Sun Kyo, Kim, Jung Hye, Kim, Jae-Ryong
  • Silencing of YY1 Downregulates RIZ1 Promoter in Human Osteosarcoma
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 1. (2008), pp. 33-41.
  • Distribution of Microsatellite Instability in Danish Ovarian Tumor Patients and the Prognostic Value in Ovarian Cancer Patients
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 17, No. 1. (2008), pp. 43-49.
  • Cellular Studies of MrDb (DDX18)
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 16, No. 12. (2007), pp. 549-556.
  • Antisense Experiments Demonstrate an Exon 4 Minus Splice Variant mRNA as the Basis for Expression of tNOX, a Cancer-Specific Cell Surface Protein
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 16, No. 12. (2007), pp. 557-567.
  • Adenosine Modulates Cell Growth in the Human Breast Cancer Cells Via Adenosine Receptors
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 16, No. 12. (2007), pp. 575-585.
  • Association of CYP1A1 Polymorphisms With Breast Cancer in North Indian Women
    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Vol. 16, No. 12. (2007), pp. 587-597.
  • Metabolites of the Radiosensitizer Nicotinamide Are Unlikely to Contribute to the Degree of Emesis Observed With the Parent Drug
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 12. (2007), pp. 569-574.
  • Cellular Studies of MrDb (DDX18)
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 12. (2008), pp. 549-556.
  • Antisense Experiments Demonstrate an Exon 4 Minus Splice Variant mRNA as the Basis for Expression of tNOX, a Cancer-Specific Cell Surface Protein
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 12. (2008), pp. 557-567.
  • Adenosine Modulates Cell Growth in the Human Breast Cancer Cells Via Adenosine Receptors
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 12. (2008), pp. 575-585.
  • Association of CYP1A1 Polymorphisms With Breast Cancer in North Indian Women
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 12. (2008), pp. 587-597.
  • The Proteomic Analysis of Cisplatin Resistance in Breast Cancer Cells
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 11. (2007), pp. 497-506.
  • Actin-Sequestering Protein, Thymosin-Beta-4 (TB4), Inhibits Caspase-3 Activation in Paclitaxel-Induced Tumor Cell Death
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 11. (2007), pp. 507-516.
  • The Effect of Combined Treatment on Head and Neck Human Cancer Cell Lines With Novel Analogs of Calcitriol and Cytostatics
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 11. (2007), pp. 517-525.
  • Alterations Found in p16RbCyclin D1 Pathway in the Dysplastic and Malignant Cervical Epithelium
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 11. (2007), pp. 527-533.
  • Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal Cancer
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 11. (2007), pp. 535-548.
  • Valproic Acid Increases the In Vitro Effects of Nitrosureas on Human Glioma Cell Lines
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 10. (2007), pp. 453-463.
  • Expression of the Human MTA1 Gene in Breast Cell Lines and in Breast Cancer Tissues
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 10. (2007), pp. 465-470.
  • Evaluation of Adenoviral Oncolytic Effect on Glioma Spheroids by 18F-DG Positron-Emission Tomography
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 10. (2007), pp. 471-477.
  • Cisplatin-Induced Senescence and Growth Inhibition in Human Non-Small Cell Lung Cancer Cells With Ectopic Transfer of p16I NK4a
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 10. (2007), pp. 479-488.
  • Short-Term Gefitinib Treatment Brought About a Long-Term Regression of Bronchioloalveolar Carcinoma Without EGFR Gene Alterations: A Case Report
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 10. (2007), pp. 489-495.
  • Functional Evidence for a Nasopharyngeal Carcinoma-Related Gene BCAT1 Located at 12p12
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 405-413.
  • Antitumor Activity of MannanMethotrexate Conjugate In Vitro and In Vivo
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 415-421.
  • The Role of GSTM1 and GSTT1 Polymorphisms in Head and Neck Cancer Risk
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 423-429.
  • Loss of Hugl-1 Expression Associates With Lymph Node Metastasis in Endometrial Cancer
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 431-435.
  • CYP1A1 Msp1 TC Polymorphism in Esophageal Cancer: No Association and Risk Modulation
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 437-443.
  • Serum Levels of VEGF-C, VEGF-D, and sVEGF-R2 in Patients With Lung Cancer During Chemotherapy
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 9. (2007), pp. 445-451.
  • TAT Peptide-Modified Liposomes Provide Enhanced Gene Delivery to Intracranial Human Brain Tumor Xenografts in Nude Mice
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 8. (2006), pp. 351-359.
  • Increased Preclinical Efficacy of Irinotecan and Floxuridine Coencapsulated Inside Liposomes Is Associated With Tumor Delivery of Synergistic Drug Ratios
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 8. (2006), pp. 361-374.
  • IL-2, TNF-, and Leptin: Local Versus Systemic Concentrations in NSCLC Patients
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 8. (2006), pp. 375-381.
  • Prenatal and Perinatal Risk Factors and Testicular Cancer: A Hospital-Based Case-Control Study
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 8. (2006), pp. 383-387.
  • Radiation-Induced Antitumor Properties of Vitamin B5 (Pantothenic Acid) and its Effect on Mitomycin C Activity: Experiments In Vitro
    Oncology Research Incorporating Anti-Cancer Drug Design, Vol. 16, No. 8. (2006), pp. 389-394.
  • Puoi citare questa pagina come: http://www.citeulike.org/journal/cog-or

    Result page: 1 2 3 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.